Duck Tembusu virus (DTMUV) is a newly identified flavivirus that was first isolated in southeastern China in 2010 (Su et al., 2011) , and has spread to Malaysia and Thailand in recent years (Homonnay et al., 2014; Thontiravong et al., 2015) . DTMUV was initially also referred to as duck eggdrop syndrome virus (DEDSV), and DTMUV-infected ducks develop a severe disease characterized by a drop in egg production, acute anorexia, retarded growth and neurological dysfunction (Yan et al., 2011b) . DTMUV infection has caused huge economic losses in duck-farming with over 10 million shelducks infected and approximately one million dead (Yan et al., 2011a) . Moreover, multiple avian species including chickens, sparrows and geese have been suggested as the hosts of DTMUV (Chen et al., 2014b; Huang et al., 2013; Liu et al., 2012a) . The rapid spread, unknown transmission routes, as well as zoonotic nature, raise serious concern about DTMUV as a potential human pathogen.
The genus Flavivirus contains a large group of human pathogens including dengue virus (DENV), West Nile virus (WNV), Japanese encephalitis virus (JEV), tick-borne encephalitis virus (TBEV), etc. Our phylogenetic analysis (Fig. S1 , available in the online Supplementary Material) together with previous studies show that all DTMUV isolates cluster within the clade of mosquito-borne flaviviruses (Liu et al., 2012b; Yun et al., 2012) , and are more closely related to the JEV serogroup (Fig. S1 ). Similar to other known flaviviruses, DTMUV has an approximately 11 kb single-stranded positive-sense RNA genome, which contains a single ORF that encodes three structural proteins (C, prM, and E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5), flanked by the 5¢ and 3¢ untranslated regions (UTRs). The structural proteins are supposed to be involved in cellular attachment, membrane fusion and virion assembly, and the nonstructural proteins are responsible for genome replication and counteraction of host immunity, in similar mechanisms to other known pathogenic flaviviruses (Avirutnan et al., 2010; Best et al., 2005; Crook et al., 2014; Jones et al., 2005; Munoz-Jordan et al., 2003; Werme et al., 2008) . DTMUV is highly pathogenic for ducks, and exhibited neurotropic effects in a mouse model Tang et al., 2013) . However, viral determinants for virulence and pathogenicity remain largely unknown.
Chimeric flaviviruses have been engineered to study pathogenesis (Yoshii et al., 2014) , replication regulation and virushost interaction (Courtney et al., 2012; Evans & Seeger, 2007; Hyde et al., 2014) . Especially, using live attenuated strains as the genetic backbone, multiple versions of chimeric flaviviruses have been successfully designed and well-explored in the development of vaccines against DENV, WNV, JEV and TBEV (Brandler et al., 2005; Chambers et al., 1999; Guirakhoo et al., 2000; Guy & Jackson, 2016; Pletnev et al., 2002; Wright et al., 2008) . The JEV live attenuated vaccine virus SA14-14-2 has been widely used in most JEV-endemic countries (Yu, 2010) with an excellent safety and efficacy profile (Bista et al., 2001; Kumar et al., 2009; Tandan et al., 2007) . Using the vaccine strain SA14-14-2 as the genetic backbone, we have successfully transferred the prM-E genes of DENV, WNV and TBEV into the corresponding position of the JEV SA14-14-2 genome, respectively, resulting in viable chimeric flaviviruses that can be further developed as vaccine candidates (Li et al., 2013b, c; Wang et al., 2014) . This study aims to create a new version of chimeric DTMUV and characterize its biological properties.
To obtain the desired chimera construct, the prM and E genes of SA14-14-2 were replaced with the corresponding genes of DTMUV strain BYD-1 (GenBank accession no. JF312912) using the subgenomic replicon of JEV SA14-14-2 developed by our lab (Li et al., 2013a) (Fig. 1a) . The resulting full-length cDNA clone retained the prM signal peptide and the last three amino acids at the terminus of the E protein of JEV to ensure efficient cleavage at the C-prM junction and E-NS1 junction, respectively (Li et al., 2013c) . Total RNA transcripts (1 mg) were obtained by in vitro transcription of linearized cDNA with SP6 RNA polymerase, and then transfected into baby hamster kidney (BHK-21) cells with Lipofectamine 3000 (Life Technology) as described previously (Li et al., 2013c) . The recovered virus, named ChinDTMUV, was harvested after onset of typical cytopathic effect. The chimeric genome structure of ChinDTMUV was confirmed by full genome sequencing (data not shown). Indirect immunofluorescence assay (IFA) was performed in BHK-21 cells infected with ChinDTMUV and its parental DTMUV and JEV, respectively. As shown in Fig. 1b , BHK-21 cells infected with ChinDTMUV or DTMUV were positive for DTMUV-specific mouse antisera but negative for JEV E protein-specific antibodies at 72 h post-infection (p.i.) (Li et al., 2013c) . As predicted, a positive reaction was observed with antibodies specific to the JEV NS1 protein (Li et al., 2013c) in cells infected with the ChinDTMUV and JEV (Fig. 1b) . Plaque-forming assays in BHK-21 cells showed that ChinDTMUV produced a homogeneous population of small plaques in comparison with its parental viruses (Fig. 1c) . The growth curves of ChinDT-MUV and its parental viruses were compared in BHK-21, Vero and DF-1 cells, respectively. In BHK-21 cells, all the tested viruses attained the peak titres at 48 h p.i. with similar growth pattern (Fig. 1d) . In Vero cells, all three viruses reached a peak titre of approximately 10 6.1 p.f.u. ml À1 at 96 h p.i., and ChinDTMUV grew faster than DTMUV before 48 h p.i (Fig. 1d) . In avian DF-1 cells, DTMUV replicated efficiently and reached the peak titre of 10 6.5 p.f.u. ml À1 at 48 h p.i, while ChinDTMUV and JEV showed restricted replication with peak titres at about 10 5.0 p.f.u. ml À1 at 48 h p.i and 96 h p.i, respectively (Fig. 1d) . Together, these observations demonstrated that a viable chimeric flavivirus ChinDTMUV with small-plaque phenotype was generated.
Next, to examine the virulence phenotype of the chimeric virus in mice, groups of 3-week-old female BALB/c mice were inoculated intraperitoneally (i.p.) or intracranially (i. c.) with serial 10-fold dilutions of ChinDTMUV and its parental viruses. All the infected animals were observed for at least 21 days for signs of illness and death. In the neuroinvasiveness test, i.p. inoculation of either ChinDTMUV, DTMUV or JEV resulted in no mortality of mice, even at a high dose of 10 6 p.f.u. (Table 1 ). In the neurovirulence test, animals i.c. inoculated with the chimeric virus exhibited typical neurological manifestations, including ruffled fur, hunched posture, and hind limb paralysis, and the same symptoms were seen in DTMUV-inoculated mice. The LD 50 of ChinDTMUV and DTMUV were calculated to be 5.89 and 7.50 p.f.u., respectively ( Table 1) . As expected, neither morbidity nor mortality was observed in the mice inoculated with indicated doses of JEV SA14-14-2 (Table 1) . These results indicate that ChinDTMUV exhibits an avirulent phenotype to mice in terms of neuroinvasiveness, while still retains high neurovirulence similar to its parental virus DTMUV.
Finally, we sought to evaluate the immunogenicity of the chimeric virus in mice. Groups of 4-week-old BALB/c mice were immunized with 10 4 or 10 5 p.f.u. of ChinDTMUV subcutaneously (s.c.). Mice immunized with PBS were used as controls. At 28 days post-inoculation, all the immunized mice were bled and serum IgG and neutralizing antibody titres against DTMUV were tested by ELISA and plaque reduction neutralization test (PRNT), respectively. As shown in Fig. 2a , high levels of IgG antibodies were observed in the mice immunized with the chimeric virus in a dose-dependent manner. Importantly, DTMUV-specific neutralizing antibodies were induced in all mice immunized with ChinDTMUV (Fig. 2b) . The geometric mean titres (GMTs) of neutralizing antibody induced by low or high doses of ChinDTMUV were 29 and 35, respectively. These findings demonstrate that ChinDTMUV is capable of inducing DTMUV-specific antibody responses in mice.
In the present study, we generated a chimeric flavivirus carrying the structural proteins of DTMUV based on JEV vaccine strain SA14-14-2. The newly emerged DTMUV was clustered within mosquito-borne flaviviruses and shared a similar genome construct, which made it possible to generate a chimeric flavivirus based on the heterologous flavivirus backbone. As expected, the prM and E gene regions of DTMUV were successfully substituted for the corresponding segment of JE vaccine strain SA14-14-2. The resulting viable chimeric virus replicated efficiently in mammalian cells like its parental viruses, but showed decreased http://jgv.microbiologyresearch.orgreplication in avian cells compared with wild-type DTMUV (Fig. 1d) . The molecular mechanism behind this may reflect the cell tropism of avian flaviviruses and deserve future investigation. Furthermore, IFA results showed that DTMUV-specific antigens were effectively expressed in an antigenically intact form in the context of ChinDTMUV (Fig. 1b) . These findings are consistent with the previous observations that chimeric flaviviruses could express the prM and E genes of heterologous flaviviruses, and exhibited growth-similar characteristics (Arroyo et al., 2001; Bhatt et al., 2000; Chambers et al., 1999; Guirakhoo et al., 2000; Pletnev et al., 2001 Pletnev et al., , 2003 .
Currently, no vaccine against DTMUV infection is available for either animals or humans. A few vaccine candidates have been proposed and tested in animals (Chen et al., 2014a; Li et al., 2014; Sun et al., 2014; Zou et al., 2014) . The high production in Vero cells, small plaque phenotype and immunogenicity in mice of ChinDTMUV profiled in our study inspired us to further explore its potential as a live attenuated vaccine candidate. Further tests in mice showed a similar virulence phenotype of ChinDTMUV to its parental virus DTMUV. This finding suggests chimerization itself failed to attenuate DTMUV, which is different from previous findings from other flavivirus members (Li et al., 2013b, c; Wang et al., 2014) . Compared with the JEV vaccine strain, ChinDTMUV exhibited obvious mouse neurovirulence, indicating the prM-E proteins of DTMUV may be the major determinants of neurovirulence, which has been documented for other flaviviruses (Gualano et al., 1998; Holzmann et al., 1990; Lee & Lobigs, 2002; Lee et al., 2004; Li et al., 2006) . Sequence alignment of flavivirus E proteins revealed a total of 141 amino acid substitutions in the DTMUV sequence relative to that of JEV vaccine strain (Fig. S2) , which are distributed throughout the E protein.
Notably, five amino acids within the DTMUV E protein including residues 107 (L-F), 138 (E-K), 177 (T-A), 244 (E-G) and 439 (K-R), which are identical to those of virulent JEV strain SA14, differ from those of the JEV vaccine strain SA14-14-2 (Fig. S2 ). These residues have been implicated to play an important role in the neurovirulence of JEV (Arroyo et al., 2001; Chen et al., 1996; Liang et al., 2009; Sumiyoshi et al., 1995; Zhang et al., 2006; Zhao et al., 2005) . The relevance of these residues for neurovirulence of DTMUV needs to be addressed in future studies.
In summary, using the genetic backbone of JEV vaccine strain SA14-14-2, we rationally generated a chimeric flavivirus ChinDTMUV capable of efficient replication in mammalian cells as well as elicitation of protective immune responses in mice. Although the chimeric DTMUV generates a small plaque phenotype in cultures, residual neurovirulence in mice hindered further development of ChinDTMUV as a vaccine candidate. Nevertheless, our chimerization experiments revealed that the mouse virulence of DTMUV was predominantly determined by the DTMUV E protein. The genetic system established in our study will help investigate the molecular basis for virulence and pathogenesis of DTMUV. 
